Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264358 | PMC |
http://dx.doi.org/10.1038/s41422-019-0270-4 | DOI Listing |
Mol Cell
February 2023
Ludwig Institute for Cancer Research, University of Oxford, Roosevelt Dr, Headington, Oxford OX3 7DQ, UK. Electronic address:
Since the early days of foundational studies of nucleic acids, many chemical moieties have been discovered to decorate RNA and DNA in diverse organisms. In mammalian cells, one of these chemical modifications, N6-methyl adenosine (m6A), is unique in a way that it is highly abundant not only on RNA polymerase II (RNAPII) transcribed, protein-coding transcripts but also on non-coding RNAs, such as ribosomal RNAs and snRNAs, mediated by distinct, evolutionarily conserved enzymes. Here, we review RNA m6A modification in the light of the recent appreciation of nuclear roles for m6A in regulating chromatin states and gene expression, as well as the recent discoveries of the evolutionarily conserved methyltransferases, which catalyze methylation of adenosine on diverse sets of RNAs.
View Article and Find Full Text PDFNat Commun
September 2022
State Key Laboratory of Genetic Engineering, Collaborative Innovation Center of Genetics and Development, Department of Biochemistry and Biophysics, Institute of Plant Biology, School of Life Sciences, Fudan University, 200438, Shanghai, China.
Int J Mol Sci
January 2022
Department of Surgery, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
N-6-methyladenosine (m6A) is the most prevalent post-transcriptional RNA modification in eukaryotic cells. The modification is reversible and can be dynamically regulated by writer and eraser enzymes. Alteration in the levels of these enzymes can lead to changes in mRNA stability, alternative splicing or microRNA processing, depending on the m6A-binding proteins.
View Article and Find Full Text PDFNucleic Acids Res
September 2020
Genome Institute of Singapore, 60 Biopolis Street, Singapore 138672, Singapore.
Cell Discov
June 2020
Department of Medicine, Division of Newborn Medicine and Epigenetics Programe, Boston Children's Hospital, Boston, MA 02115 USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!